• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制障碍与肛门鳞状细胞癌风险:丹麦 1978-2005 年全国队列研究。

Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005.

机构信息

Department of Colorectal Surgery P, Aarhus Hospital, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Int J Cancer. 2010 Aug 1;127(3):675-84. doi: 10.1002/ijc.25080.

DOI:10.1002/ijc.25080
PMID:19960431
Abstract

Compromised immune function may increase the risk of anal squamous cell carcinoma (SCC). We examined the risk of anal SCC in patients with HIV infection and other chronic disorders associated with immunosuppression. A population-based cohort study was conducted using the Danish National Patient Registry and the Danish Cancer Registry (DCR). We identified all patients with a first-time hospital contact or procedure for HIV infection, solid organ transplantation or autoimmune disease or a first-time record of haematologic malignancy in the DCR, 1978-2005, and followed these for a subsequent anal SCC, starting follow-up 1 year after diagnosis of the index disease. Standardised incidence ratios (SIRs) were computed as the ratio of observed to expected numbers of anal SCCs, based on national age-, sex- and period-specific rates. Among 4,488 patients with HIV, we observed 21 anal SCCs with 0.3 expected (SIR: 81.1 (95% confidence interval (CI): 51.6-121.9)). Risk of anal SCC was markedly increased among 5,113 solid organ recipients (SIR: 14.4 (CI: 7.0-26.4)) and 30,165 patients with haematologic malignancies (SIR: 2.3 (CI: 1.1-4.2)) but only moderately increased among 242,114 patients with autoimmune diseases (SIR: 1.3 (CI: 1.0-1.6)). SIRs varied according to type of autoimmune disease and were high in patients with Crohn's disease (SIR: 3.1 (CI: 1.2-6.4)), psoriasis (SIR: 3.1 (CI: 1.8-5.1)), polyarteritis nodosa (SIR: 8.8 (CI: 1.5-29.0)) and Wegener's granulomatosis (SIR: 12.4 (CI: 2.1-40.8)). In conclusion, we found HIV infection, solid organ transplantation, haematologic malignancies and a range of specific autoimmune diseases strongly associated with increased risk of anal SCC.

摘要

免疫功能受损可能会增加肛门鳞状细胞癌(SCC)的风险。我们研究了感染 HIV 以及其他与免疫抑制相关的慢性疾病患者肛门 SCC 的风险。该研究采用了丹麦全国患者登记处和丹麦癌症登记处(DCR)进行了一项基于人群的队列研究。我们在 DCR 中确定了所有首次因 HIV 感染、实体器官移植或自身免疫性疾病住院或接受治疗的患者,或首次记录血液恶性肿瘤的患者,并从诊断出该疾病后开始随访 1 年,随后观察这些患者是否发生肛门 SCC。标准化发病比(SIR)是通过观察到的肛门 SCC 数量与基于全国年龄、性别和时期特定发病率的预期数量计算得出的比值。在 4488 名 HIV 患者中,我们观察到 21 例肛门 SCC,预期为 0.3 例(SIR:81.1(95%置信区间(CI):51.6-121.9))。实体器官受者(SIR:14.4(CI:7.0-26.4))和 30165 名血液恶性肿瘤患者(SIR:2.3(CI:1.1-4.2))发生肛门 SCC 的风险显著增加,但 242114 名自身免疫性疾病患者(SIR:1.3(CI:1.0-1.6))的风险仅中度增加。SIR 因自身免疫性疾病的类型而异,在克罗恩病(SIR:3.1(CI:1.2-6.4))、银屑病(SIR:3.1(CI:1.8-5.1))、结节性多动脉炎(SIR:8.8(CI:1.5-29.0))和 Wegener 肉芽肿(SIR:12.4(CI:2.1-40.8))患者中较高。总之,我们发现 HIV 感染、实体器官移植、血液恶性肿瘤和一系列特定的自身免疫性疾病与肛门 SCC 风险增加密切相关。

相似文献

1
Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005.免疫抑制障碍与肛门鳞状细胞癌风险:丹麦 1978-2005 年全国队列研究。
Int J Cancer. 2010 Aug 1;127(3):675-84. doi: 10.1002/ijc.25080.
2
Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?免疫抑制人群中的直肠鳞状细胞癌:这是否是一种与肛门癌不同的实体?
AIDS. 2016 Jan 2;30(1):105-12. doi: 10.1097/QAD.0000000000000873.
3
Elevated anal squamous cell carcinoma risk associated with benign inflammatory anal lesions.与良性炎性肛门病变相关的肛门鳞状细胞癌风险升高。
Gut. 2006 May;55(5):703-7. doi: 10.1136/gut.2005.070201. Epub 2005 Nov 18.
4
Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.丹麦全国范围内的队列研究:实体器官受者的皮肤癌风险。
Acta Derm Venereol. 2010 Sep;90(5):474-9. doi: 10.2340/00015555-0919.
5
Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.1970 年至 2008 年瑞典人群研究:肾、肝、心、肺移植受者的皮肤癌和其他恶性肿瘤风险。
Int J Cancer. 2013 Mar 15;132(6):1429-38. doi: 10.1002/ijc.27765. Epub 2012 Aug 28.
6
On the etiology of anal squamous carcinoma.关于肛门鳞状细胞癌的病因学。
Dan Med Bull. 2002 Aug;49(3):194-209.
7
Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men.HIV 感染的男男性行为人群中异常肛门细胞学和高级别鳞状上皮内病变的流行率。
Dis Colon Rectum. 2014 Apr;57(4):475-81. doi: 10.1097/DCR.0000000000000095.
8
Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.器官移植后皮肤癌风险的长期变化:基于人群的全国队列研究。
JAMA Dermatol. 2017 Dec 1;153(12):1270-1277. doi: 10.1001/jamadermatol.2017.2984.
9
Anal carcinoma in HIV-infected patients in the period 1995-2009: a Danish nationwide cohort study.1995年至2009年期间丹麦全国队列研究:HIV感染患者的肛门癌
Scand J Infect Dis. 2013 Jun;45(6):453-9. doi: 10.3109/00365548.2012.737476. Epub 2013 Jan 7.
10
Merkel cell carcinoma: incidence, mortality, and risk of other cancers. Merkel 细胞癌:发病率、死亡率和其他癌症风险。
J Natl Cancer Inst. 2010 Jun 2;102(11):793-801. doi: 10.1093/jnci/djq120. Epub 2010 Apr 27.

引用本文的文献

1
Human Papillomavirus-Encoded microRNAs as Regulators of Human Gene Expression in Anal Squamous Cell Carcinoma: A Meta-Transcriptomics Study.人乳头瘤病毒编码的微小RNA作为肛门鳞状细胞癌中人类基因表达的调节因子:一项元转录组学研究
Noncoding RNA. 2025 Jun 9;11(3):43. doi: 10.3390/ncrna11030043.
2
Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer.局部蛋白酶抑制剂可提高 CD4 耗竭的肛门癌小鼠模型的无肿瘤和总生存。
Viruses. 2024 Sep 5;16(9):1421. doi: 10.3390/v16091421.
3
Anal carcinoma - exploring the epidemiology, risk factors, pathophysiology, diagnosis, and treatment.
肛管癌——探索其流行病学、危险因素、病理生理学、诊断及治疗。
World J Exp Med. 2024 Sep 20;14(3):98525. doi: 10.5493/wjem.v14.i3.98525.
4
ANAL CANCER IN A RENAL TRANSPLANT RECIPIENT: A CASE REPORT AND LITERATURE REVIEW.肾移植受者的肛门癌:病例报告及文献复习。
Acta Clin Croat. 2023 Nov;62(3):556-560. doi: 10.20471/acc.2023.62.03.19.
5
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination.人乳头瘤病毒相关癌症的过去、现在和未来的流行病学:走向预防和消除。
Nat Rev Clin Oncol. 2024 Jul;21(7):522-538. doi: 10.1038/s41571-024-00904-z. Epub 2024 May 17.
6
Autoimmune disease and the risk of anal cancer in the US population aged 66 years and over.自身免疫性疾病与美国 66 岁及以上人群肛门癌风险的相关性。
J Natl Cancer Inst. 2024 Feb 8;116(2):309-315. doi: 10.1093/jnci/djad187.
7
Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan.日本肛门管鳞癌的特征,作为一种 HPV 相关癌症。
Int J Clin Oncol. 2023 Aug;28(8):990-998. doi: 10.1007/s10147-023-02339-5. Epub 2023 Apr 28.
8
[Diagnostics, treatment and aftercare of anal cancer].[肛管癌的诊断、治疗及术后护理]
Chirurgie (Heidelb). 2023 Oct;94(10):890-898. doi: 10.1007/s00104-023-01849-2. Epub 2023 Apr 12.
9
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).一项评估 INCMGA00012(Retifanlimab)在接受铂类化疗(POD1UM-202)后进展的局部晚期或转移性肛门鳞癌患者中的疗效和安全性的多中心、开放标签、单臂 II 期临床研究。
ESMO Open. 2022 Aug;7(4):100529. doi: 10.1016/j.esmoop.2022.100529. Epub 2022 Jul 8.
10
A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer.一项关于 3 级肛门上皮内瘤变进展为肛门癌的危险因素的全国性纵向研究。
Int J Cancer. 2022 Oct 15;151(8):1240-1247. doi: 10.1002/ijc.34143. Epub 2022 Jun 15.